Breast cancer–specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast
Previous studies on the efficacy of primary treatments for ductal carcinoma-in-situ (DCIS) have focused on local recurrence rates. Our objective was to detail the outcomes of local invasive recurrence, distant recurrence, and breast cancer mortality in patients previously treated for DCIS. Clinical,...
Gespeichert in:
Veröffentlicht in: | The American journal of surgery 2006-10, Vol.192 (4), p.416-419 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 419 |
---|---|
container_issue | 4 |
container_start_page | 416 |
container_title | The American journal of surgery |
container_volume | 192 |
creator | Lee, Laura A. Silverstein, Melvin J. Chung, Cathie T. Macdonald, Heather Sanghavi, Premal Epstein, Melinda Holmes, Dennis R. Silberman, Howard Ye, Wei Lagios, Michael D. |
description | Previous studies on the efficacy of primary treatments for ductal carcinoma-in-situ (DCIS) have focused on local recurrence rates. Our objective was to detail the outcomes of local invasive recurrence, distant recurrence, and breast cancer mortality in patients previously treated for DCIS.
Clinical, pathologic, and outcome data were collected prospectively for 1236 patients with pure DCIS accrued from 1972 through 2005.
There were 150 recurrences (87 DCIS and 63 invasive). Invasive local recurrence after mastectomy was rare (0.5% of patients) and after breast preservation was more frequent (12.0% of patients). The 12-year probabilities of breast cancer-specific mortality after mastectomy and after breast preservation were 0.8% and 1.0%, respectively. The 12-year breast cancer-specific mortality and distant disease probability for the 63 patients with invasive recurrences were 12% and 15%, respectively.
Regardless of initial treatment, most patients with invasive local recurrence after treatment for DCIS can be treated and cured. |
doi_str_mv | 10.1016/j.amjsurg.2006.06.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68860895</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002961006004478</els_id><sourcerecordid>3107782851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-7cf4a3c24041235a7a024517d0e0d57a0b62797eb095ffe4f4ca505f223be2533</originalsourceid><addsrcrecordid>eNqFkd2K1TAQx4Mo7nH1EZSAuHc9TtIkba9El_UDFrzR65CmEzelH8ckPbJe-Q6-oU9i6ikseKEwEIb8ZvInP0KeMtgzYOplvzdjH5fwZc8B1H4tkPfIjtVVU7C6Lu-THQDwolEMzsijGPvcMibKh-SMqaaqGwE78v1NQBMTtWayGH79-BkPaL3zlo5zSGbw6ZYalzBQPx1N9Eekw2zNQAPaJQTMU_mGHkzyOKVIv_l0Q7vF5tG8M1g_zaMp_FREnxY6O5pukLZ_3nxMHjgzRHyynefk89urT5fvi-uP7z5cvr4urBBNKirrhCktFyAYL6WpDHAhWdUBQidz1ypeNRW20EjnUDhhjQTpOC9b5LIsz8nFae8hzF8XjEmPPlocBjPhvESt6lpB3cgMPv8L7OclTDmbZkIIxSrgzT8pKBlnijUqU_JE2TDHGNDpQ_CjCbcZ0qtA3etNoF4F6rVgzfBs2760I3Z3U5uxDLzYABOzBxeyOB_vuJpzydTKvTpxmL_26DHoaP2qq_NZXdLd7P8T5TeUW70Z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031216196</pqid></control><display><type>article</type><title>Breast cancer–specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lee, Laura A. ; Silverstein, Melvin J. ; Chung, Cathie T. ; Macdonald, Heather ; Sanghavi, Premal ; Epstein, Melinda ; Holmes, Dennis R. ; Silberman, Howard ; Ye, Wei ; Lagios, Michael D.</creator><creatorcontrib>Lee, Laura A. ; Silverstein, Melvin J. ; Chung, Cathie T. ; Macdonald, Heather ; Sanghavi, Premal ; Epstein, Melinda ; Holmes, Dennis R. ; Silberman, Howard ; Ye, Wei ; Lagios, Michael D.</creatorcontrib><description>Previous studies on the efficacy of primary treatments for ductal carcinoma-in-situ (DCIS) have focused on local recurrence rates. Our objective was to detail the outcomes of local invasive recurrence, distant recurrence, and breast cancer mortality in patients previously treated for DCIS.
Clinical, pathologic, and outcome data were collected prospectively for 1236 patients with pure DCIS accrued from 1972 through 2005.
There were 150 recurrences (87 DCIS and 63 invasive). Invasive local recurrence after mastectomy was rare (0.5% of patients) and after breast preservation was more frequent (12.0% of patients). The 12-year probabilities of breast cancer-specific mortality after mastectomy and after breast preservation were 0.8% and 1.0%, respectively. The 12-year breast cancer-specific mortality and distant disease probability for the 63 patients with invasive recurrences were 12% and 15%, respectively.
Regardless of initial treatment, most patients with invasive local recurrence after treatment for DCIS can be treated and cured.</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/j.amjsurg.2006.06.005</identifier><identifier>PMID: 16978940</identifier><identifier>CODEN: AJSUAB</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Breast cancer ; Breast cancer mortality ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Cancer therapies ; Carcinoma, Intraductal, Noninfiltrating - mortality ; Carcinoma, Intraductal, Noninfiltrating - secondary ; Carcinoma, Intraductal, Noninfiltrating - surgery ; DCIS ; Disease-Free Survival ; Ductal carcinoma-in-situ ; Female ; Follow-Up Studies ; General aspects ; Gynecology. Andrology. Obstetrics ; Humans ; Local recurrence ; Mammary gland diseases ; Mammography ; Mastectomy ; Medical sciences ; Mortality ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Patients ; Probability ; Prospective Studies ; Radiation therapy ; Survival Rate ; Therapy ; Treatment Outcome ; Tumors</subject><ispartof>The American journal of surgery, 2006-10, Vol.192 (4), p.416-419</ispartof><rights>2006 Excerpta Medica Inc.</rights><rights>2006 INIST-CNRS</rights><rights>Copyright Elsevier Limited Oct 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-7cf4a3c24041235a7a024517d0e0d57a0b62797eb095ffe4f4ca505f223be2533</citedby><cites>FETCH-LOGICAL-c449t-7cf4a3c24041235a7a024517d0e0d57a0b62797eb095ffe4f4ca505f223be2533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002961006004478$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18225160$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16978940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Laura A.</creatorcontrib><creatorcontrib>Silverstein, Melvin J.</creatorcontrib><creatorcontrib>Chung, Cathie T.</creatorcontrib><creatorcontrib>Macdonald, Heather</creatorcontrib><creatorcontrib>Sanghavi, Premal</creatorcontrib><creatorcontrib>Epstein, Melinda</creatorcontrib><creatorcontrib>Holmes, Dennis R.</creatorcontrib><creatorcontrib>Silberman, Howard</creatorcontrib><creatorcontrib>Ye, Wei</creatorcontrib><creatorcontrib>Lagios, Michael D.</creatorcontrib><title>Breast cancer–specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast</title><title>The American journal of surgery</title><addtitle>Am J Surg</addtitle><description>Previous studies on the efficacy of primary treatments for ductal carcinoma-in-situ (DCIS) have focused on local recurrence rates. Our objective was to detail the outcomes of local invasive recurrence, distant recurrence, and breast cancer mortality in patients previously treated for DCIS.
Clinical, pathologic, and outcome data were collected prospectively for 1236 patients with pure DCIS accrued from 1972 through 2005.
There were 150 recurrences (87 DCIS and 63 invasive). Invasive local recurrence after mastectomy was rare (0.5% of patients) and after breast preservation was more frequent (12.0% of patients). The 12-year probabilities of breast cancer-specific mortality after mastectomy and after breast preservation were 0.8% and 1.0%, respectively. The 12-year breast cancer-specific mortality and distant disease probability for the 63 patients with invasive recurrences were 12% and 15%, respectively.
Regardless of initial treatment, most patients with invasive local recurrence after treatment for DCIS can be treated and cured.</description><subject>Biological and medical sciences</subject><subject>Breast cancer</subject><subject>Breast cancer mortality</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Cancer therapies</subject><subject>Carcinoma, Intraductal, Noninfiltrating - mortality</subject><subject>Carcinoma, Intraductal, Noninfiltrating - secondary</subject><subject>Carcinoma, Intraductal, Noninfiltrating - surgery</subject><subject>DCIS</subject><subject>Disease-Free Survival</subject><subject>Ductal carcinoma-in-situ</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>General aspects</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Local recurrence</subject><subject>Mammary gland diseases</subject><subject>Mammography</subject><subject>Mastectomy</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Patients</subject><subject>Probability</subject><subject>Prospective Studies</subject><subject>Radiation therapy</subject><subject>Survival Rate</subject><subject>Therapy</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkd2K1TAQx4Mo7nH1EZSAuHc9TtIkba9El_UDFrzR65CmEzelH8ckPbJe-Q6-oU9i6ikseKEwEIb8ZvInP0KeMtgzYOplvzdjH5fwZc8B1H4tkPfIjtVVU7C6Lu-THQDwolEMzsijGPvcMibKh-SMqaaqGwE78v1NQBMTtWayGH79-BkPaL3zlo5zSGbw6ZYalzBQPx1N9Eekw2zNQAPaJQTMU_mGHkzyOKVIv_l0Q7vF5tG8M1g_zaMp_FREnxY6O5pukLZ_3nxMHjgzRHyynefk89urT5fvi-uP7z5cvr4urBBNKirrhCktFyAYL6WpDHAhWdUBQidz1ypeNRW20EjnUDhhjQTpOC9b5LIsz8nFae8hzF8XjEmPPlocBjPhvESt6lpB3cgMPv8L7OclTDmbZkIIxSrgzT8pKBlnijUqU_JE2TDHGNDpQ_CjCbcZ0qtA3etNoF4F6rVgzfBs2760I3Z3U5uxDLzYABOzBxeyOB_vuJpzydTKvTpxmL_26DHoaP2qq_NZXdLd7P8T5TeUW70Z</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Lee, Laura A.</creator><creator>Silverstein, Melvin J.</creator><creator>Chung, Cathie T.</creator><creator>Macdonald, Heather</creator><creator>Sanghavi, Premal</creator><creator>Epstein, Melinda</creator><creator>Holmes, Dennis R.</creator><creator>Silberman, Howard</creator><creator>Ye, Wei</creator><creator>Lagios, Michael D.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20061001</creationdate><title>Breast cancer–specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast</title><author>Lee, Laura A. ; Silverstein, Melvin J. ; Chung, Cathie T. ; Macdonald, Heather ; Sanghavi, Premal ; Epstein, Melinda ; Holmes, Dennis R. ; Silberman, Howard ; Ye, Wei ; Lagios, Michael D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-7cf4a3c24041235a7a024517d0e0d57a0b62797eb095ffe4f4ca505f223be2533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>Breast cancer</topic><topic>Breast cancer mortality</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Cancer therapies</topic><topic>Carcinoma, Intraductal, Noninfiltrating - mortality</topic><topic>Carcinoma, Intraductal, Noninfiltrating - secondary</topic><topic>Carcinoma, Intraductal, Noninfiltrating - surgery</topic><topic>DCIS</topic><topic>Disease-Free Survival</topic><topic>Ductal carcinoma-in-situ</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>General aspects</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Local recurrence</topic><topic>Mammary gland diseases</topic><topic>Mammography</topic><topic>Mastectomy</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Patients</topic><topic>Probability</topic><topic>Prospective Studies</topic><topic>Radiation therapy</topic><topic>Survival Rate</topic><topic>Therapy</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Laura A.</creatorcontrib><creatorcontrib>Silverstein, Melvin J.</creatorcontrib><creatorcontrib>Chung, Cathie T.</creatorcontrib><creatorcontrib>Macdonald, Heather</creatorcontrib><creatorcontrib>Sanghavi, Premal</creatorcontrib><creatorcontrib>Epstein, Melinda</creatorcontrib><creatorcontrib>Holmes, Dennis R.</creatorcontrib><creatorcontrib>Silberman, Howard</creatorcontrib><creatorcontrib>Ye, Wei</creatorcontrib><creatorcontrib>Lagios, Michael D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Laura A.</au><au>Silverstein, Melvin J.</au><au>Chung, Cathie T.</au><au>Macdonald, Heather</au><au>Sanghavi, Premal</au><au>Epstein, Melinda</au><au>Holmes, Dennis R.</au><au>Silberman, Howard</au><au>Ye, Wei</au><au>Lagios, Michael D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breast cancer–specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast</atitle><jtitle>The American journal of surgery</jtitle><addtitle>Am J Surg</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>192</volume><issue>4</issue><spage>416</spage><epage>419</epage><pages>416-419</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><coden>AJSUAB</coden><abstract>Previous studies on the efficacy of primary treatments for ductal carcinoma-in-situ (DCIS) have focused on local recurrence rates. Our objective was to detail the outcomes of local invasive recurrence, distant recurrence, and breast cancer mortality in patients previously treated for DCIS.
Clinical, pathologic, and outcome data were collected prospectively for 1236 patients with pure DCIS accrued from 1972 through 2005.
There were 150 recurrences (87 DCIS and 63 invasive). Invasive local recurrence after mastectomy was rare (0.5% of patients) and after breast preservation was more frequent (12.0% of patients). The 12-year probabilities of breast cancer-specific mortality after mastectomy and after breast preservation were 0.8% and 1.0%, respectively. The 12-year breast cancer-specific mortality and distant disease probability for the 63 patients with invasive recurrences were 12% and 15%, respectively.
Regardless of initial treatment, most patients with invasive local recurrence after treatment for DCIS can be treated and cured.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16978940</pmid><doi>10.1016/j.amjsurg.2006.06.005</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9610 |
ispartof | The American journal of surgery, 2006-10, Vol.192 (4), p.416-419 |
issn | 0002-9610 1879-1883 |
language | eng |
recordid | cdi_proquest_miscellaneous_68860895 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Biological and medical sciences Breast cancer Breast cancer mortality Breast Neoplasms - mortality Breast Neoplasms - pathology Breast Neoplasms - surgery Cancer therapies Carcinoma, Intraductal, Noninfiltrating - mortality Carcinoma, Intraductal, Noninfiltrating - secondary Carcinoma, Intraductal, Noninfiltrating - surgery DCIS Disease-Free Survival Ductal carcinoma-in-situ Female Follow-Up Studies General aspects Gynecology. Andrology. Obstetrics Humans Local recurrence Mammary gland diseases Mammography Mastectomy Medical sciences Mortality Neoplasm Invasiveness Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery Patients Probability Prospective Studies Radiation therapy Survival Rate Therapy Treatment Outcome Tumors |
title | Breast cancer–specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T12%3A44%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breast%20cancer%E2%80%93specific%20mortality%20after%20invasive%20local%20recurrence%20in%20patients%20with%20ductal%20carcinoma-in-situ%20of%20the%20breast&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Lee,%20Laura%20A.&rft.date=2006-10-01&rft.volume=192&rft.issue=4&rft.spage=416&rft.epage=419&rft.pages=416-419&rft.issn=0002-9610&rft.eissn=1879-1883&rft.coden=AJSUAB&rft_id=info:doi/10.1016/j.amjsurg.2006.06.005&rft_dat=%3Cproquest_cross%3E3107782851%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1031216196&rft_id=info:pmid/16978940&rft_els_id=S0002961006004478&rfr_iscdi=true |